加拿大pc

 

甲狀腺乳腺外科

甲狀腺乳腺外科

加拿大pc開(kai)獎(jiang)甲(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)外(wai)科的(de)(de)前(qian)身(shen)是普(pu)外(wai)科,目(mu)前(qian)擁有醫(yi)(yi)師(shi)(shi)22名(ming)(ming)(ming),其中主(zhu)(zhu)(zhu)任(ren)醫(yi)(yi)師(shi)(shi)2名(ming)(ming)(ming),副(fu)(fu)主(zhu)(zhu)(zhu)任(ren)醫(yi)(yi)師(shi)(shi)2名(ming)(ming)(ming),主(zhu)(zhu)(zhu)治醫(yi)(yi)師(shi)(shi)9名(ming)(ming)(ming),住院醫(yi)(yi)師(shi)(shi)9名(ming)(ming)(ming),博士(shi)生導師(shi)(shi)1名(ming)(ming)(ming),醫(yi)(yi)學博士(shi)5名(ming)(ming)(ming),碩(shuo)士(shi)16名(ming)(ming)(ming)。護理人員30名(ming)(ming)(ming),其中,副(fu)(fu)主(zhu)(zhu)(zhu)任(ren)護師(shi)(shi)1名(ming)(ming)(ming),主(zhu)(zhu)(zhu)管護師(shi)(shi)11名(ming)(ming)(ming),形(xing)成了完整的(de)(de)人才(cai)梯隊(dui)體(ti)系。2009年,隨著(zhu)住院一(yi)部的(de)(de)啟用,為適應醫(yi)(yi)學發展(zhan)專業化、精細化的(de)(de)要求(qiu),醫(yi)(yi)院決定將(jiang)普(pu)外(wai)二科更名(ming)(ming)(ming)為甲(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)外(wai)科,隨即(ji)科室(shi)主(zhu)(zhu)(zhu)任(ren)楊振林根(gen)據(ju)醫(yi)(yi)院依托,帶(dai)領大家努力(li)轉(zhuan)型,將(jiang)科室(shi)工作(zuo)重心轉(zhuan)移(yi)(yi)到甲(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)疾(ji)病(bing)。臨床(chuang)上,圍(wei)繞甲(jia)(jia)狀(zhuang)腺(xian)(xian)(xian)(xian)乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)疾(ji)病(bing)不(bu)斷(duan)開(kai)展(zhan)新(xin)技(ji)術(shu)(shu)(shu)新(xin)項目(mu),乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)方面包括: 不(bu)改(gai)變乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)外(wai)形(xing)的(de)(de)多種保乳(ru)(ru)(ru)(ru)手術(shu)(shu)(shu)(腺(xian)(xian)(xian)(xian)體(ti)肌(ji)皮瓣轉(zhuan)移(yi)(yi)、背(bei)闊肌(ji)周(zhou)圍(wei)肌(ji)筋膜(mo)轉(zhuan)移(yi)(yi)及(ji)創(chuang)腔(qiang)周(zhou)圍(wei)帶(dai)血管蒂轉(zhuan)移(yi)(yi)等)、乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)癌根(gen)治術(shu)(shu)(shu)后即(ji)刻再(zai)(zai)造(zao)(zao)(zao)成形(xing)術(shu)(shu)(shu)(背(bei)闊肌(ji)、背(bei)闊肌(ji)聯合(he)假體(ti)再(zai)(zai)造(zao)(zao)(zao)、腹(fu)直肌(ji)自體(ti)再(zai)(zai)造(zao)(zao)(zao)、雙平面假體(ti)再(zai)(zai)造(zao)(zao)(zao)、擴(kuo)張器皮下(xia)植入(ru)二次假體(ti)植入(ru)再(zai)(zai)造(zao)(zao)(zao))、常規(gui)保留胸外(wai)側及(ji)肋間壁神經的(de)(de)乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)癌改(gai)良根(gen)治術(shu)(shu)(shu)、Mammotome 乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)微(wei)創(chuang)手術(shu)(shu)(shu)、乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)MRI診斷(duan)隱匿性乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)癌、乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)癌前(qian)哨淋巴(ba)結活(huo)檢(常規(gui)術(shu)(shu)(shu)中實施、彩(cai)超引導下(xia)的(de)(de)活(huo)檢)、乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)彩(cai)超全容積成像技(ji)術(shu)(shu)(shu)、乳(ru)(ru)(ru)(ru)腺(xian)(xian)(xian)(xian)專用伽馬顯像技(ji)術(shu)(shu)(shu)等。近(jin)兩(liang)年結合(he)Breast Reconstruction (Oncoplastic?Surgery)理(li)念把整(zheng)形(xing)技術(shu)貫徹到乳(ru)(ru)(ru)腺(xian)(xian)良惡性疾病(bing)手(shou)術(shu)中,如巨乳(ru)(ru)(ru)雙側上提(ti)縮乳(ru)(ru)(ru)術(shu),極(ji)(ji)大(da)提(ti)高了乳(ru)(ru)(ru)腺(xian)(xian)外形(xing)術(shu)后的(de)(de)(de)滿(man)意(yi)度(du),200多(duo)例(li)復雜性非哺乳(ru)(ru)(ru)期乳(ru)(ru)(ru)腺(xian)(xian)炎的(de)(de)(de)治(zhi)(zhi)療(liao),病(bing)人(ren)滿(man)意(yi)度(du)達到95%以上,結合(he)VSD技術(shu)大(da)大(da)縮短了病(bing)人(ren)的(de)(de)(de)愈合(he)時間(jian)。重度(du)下(xia)(xia)垂乳(ru)(ru)(ru)房的(de)(de)(de)雙側乳(ru)(ru)(ru)腺(xian)(xian)癌NSM+乳(ru)(ru)(ru)頭乳(ru)(ru)(ru)暈上提(ti)+一(yi)(yi)期假(jia)體(ti)雙平面植(zhi)入術(shu)+前(qian)哨淋巴結活檢(jian)術(shu),此手(shou)術(shu)國(guo)(guo)際報(bao)道(dao)11例(li);吸(xi)脂(zhi)術(shu)+單孔腔鏡(jing)下(xia)(xia)保(bao)留(liu)乳(ru)(ru)(ru)頭乳(ru)(ru)(ru)暈的(de)(de)(de)乳(ru)(ru)(ru)腺(xian)(xian)癌切除+背闊肌一(yi)(yi)期重建術(shu),為國(guo)(guo)內領先。近期還開(kai)展了男(nan)性乳(ru)(ru)(ru)房肥大(da)的(de)(de)(de)脂(zhi)肪抽吸(xi)治(zhi)(zhi)療(liao)、二次乳(ru)(ru)(ru)腺(xian)(xian)整(zheng)形(xing)的(de)(de)(de)自體(ti)脂(zhi)肪移植(zhi)等(deng),均獲得了滿(man)意(yi)的(de)(de)(de)效果(guo)。 甲(jia)狀腺(xian)(xian)方面包(bao)括: 彩超引導下(xia)(xia)定位穿刺活檢(jian)、小切口(kou)改(gai)(gai)良miccoli甲(jia)狀腺(xian)(xian)癌改(gai)(gai)良根(gen)治(zhi)(zhi)術(shu)、腔鏡(jing)下(xia)(xia)甲(jia)狀腺(xian)(xian)癌根(gen)治(zhi)(zhi)術(shu)、3D-打印巨大(da)甲(jia)狀腺(xian)(xian)腫及(ji)(ji)甲(jia)狀旁腺(xian)(xian)定位手(shou)術(shu)、甲(jia)狀旁腺(xian)(xian)的(de)(de)(de)微(wei)創(chuang)手(shou)術(shu)等(deng),同時積極(ji)(ji)籌備彩超引導下(xia)(xia)的(de)(de)(de)甲(jia)狀腺(xian)(xian)結節微(wei)波及(ji)(ji)射頻(pin)消融術(shu)。我(wo)科(ke)以“呵護(hu)女性健(jian)康,綻放美(mei)麗人(ren)生”為理(li)念,竭誠(cheng)為廣大(da)患者提(ti)供最優質的(de)(de)(de)醫療(liao)服務(wu)(wu)。目(mu)前(qian),我(wo)科(ke)積極(ji)(ji)籌備建設(she)集檢(jian)查、診(zhen)斷、治(zhi)(zhi)療(liao)于一(yi)(yi)體(ti)的(de)(de)(de)門診(zhen)一(yi)(yi)體(ti)治(zhi)(zhi)療(liao)部,以便為患者提(ti)供更加(jia)便捷、高效的(de)(de)(de)服務(wu)(wu)。

科(ke)(ke)(ke)研(yan)上,與臨(lin)床(chuang)(chuang)科(ke)(ke)(ke)室疾(ji)(ji)病相結合(he)(he),專(zhuan)攻乳腺及甲狀(zhuang)腺疾(ji)(ji)病的科(ke)(ke)(ke)學研(yan)究(jiu)(jiu)(jiu)(jiu),并以(yi)此申(shen)請甲狀(zhuang)腺乳腺外科(ke)(ke)(ke)疾(ji)(ji)病的課(ke)題(ti)。楊振林博士(shi)(shi)時刻(ke)把握甲狀(zhuang)腺乳腺疾(ji)(ji)病研(yan)究(jiu)(jiu)(jiu)(jiu)領域的科(ke)(ke)(ke)研(yan)動態(tai),關注此領域的前沿(yan)研(yan)究(jiu)(jiu)(jiu)(jiu)進展,承擔和(he)完成(cheng)多項(xiang)國(guo)(guo)家自(zi)然(ran)科(ke)(ke)(ke)學基(ji)(ji)金(jin)、省部級和(he)校級科(ke)(ke)(ke)研(yan)項(xiang)目,包括(kuo)國(guo)(guo)家自(zi)然(ran)科(ke)(ke)(ke)學基(ji)(ji)金(jin)課(ke)題(ti)《補骨脂制(zhi)劑及其(qi)主(zhu)(zhu)要單(dan)體(ti)逆轉乳腺癌干(gan)(gan)細(xi)胞(bao)(bao)多藥(yao)耐(nai)(nai)藥(yao)的實(shi)驗研(yan)究(jiu)(jiu)(jiu)(jiu)》、《誘(you)導(dao)(dao)乳腺癌干(gan)(gan)細(xi)胞(bao)(bao)分(fen)化(hua)并實(shi)施(shi)化(hua)療的實(shi)驗研(yan)究(jiu)(jiu)(jiu)(jiu)》,衛(wei)生(sheng)(sheng)部課(ke)題(ti)《熒光原位雜交技(ji)術(shu)(shu)在(zai)產(chan)前遺傳性(xing)疾(ji)(ji)病及部分(fen)腫瘤檢測的多中(zhong)心臨(lin)床(chuang)(chuang)應(ying)用(yong)研(yan)究(jiu)(jiu)(jiu)(jiu)》,國(guo)(guo)家衛(wei)生(sheng)(sheng)部專(zhuan)項(xiang)基(ji)(ji)金(jin)《連續性(xing)血液凈化(hua)(CBP)在(zai)治療腹腔間隔室綜合(he)(he)癥(ACS)中(zhong)的應(ying)用(yong)》,國(guo)(guo)家衛(wei)生(sheng)(sheng)部重點項(xiang)目《乳腺癌高危人(ren)群篩選及評估體(ti)系的建(jian)立與完善》,山(shan)東省自(zi)然(ran)科(ke)(ke)(ke)學基(ji)(ji)金(jin)《整合(he)(he)素αvβ6及其(qi)靶(ba)向5-FU脂質體(ti)在(zai)結腸癌化(hua)療耐(nai)(nai)藥(yao)中(zhong)的作用(yong)》、《Sorafenib防止(zhi)肝(gan)癌肝(gan)移(yi)植后術(shu)(shu)后復發(fa)的研(yan)究(jiu)(jiu)(jiu)(jiu)》、《乳腺原發(fa)癌和(he)淋巴(ba)結轉移(yi)癌干(gan)(gan)細(xi)胞(bao)(bao)分(fen)離(li)及其(qi)信(xin)號通(tong)路(lu)分(fen)子(zi)的比較研(yan)究(jiu)(jiu)(jiu)(jiu)》、《超聲光散射聯合(he)(he)彈(dan)性(xing)成(cheng)像技(ji)術(shu)(shu)診斷(duan)乳腺腫瘤》,山(shan)東省醫藥(yao)衛(wei)生(sheng)(sheng)科(ke)(ke)(ke)技(ji)發(fa)展計(ji)劃《乳腺癌干(gan)(gan)細(xi)胞(bao)(bao)分(fen)離(li)鑒定(ding)和(he)耐(nai)(nai)藥(yao)情況的研(yan)究(jiu)(jiu)(jiu)(jiu)》,山(shan)東省高等(deng)學校科(ke)(ke)(ke)技(ji)計(ji)劃項(xiang)目《組織型轉谷(gu)氨酰胺酶介導(dao)(dao)乳腺癌干(gan)(gan)細(xi)胞(bao)(bao)多藥(yao)耐(nai)(nai)藥(yao)機制(zhi)的實(shi)驗研(yan)究(jiu)(jiu)(jiu)(jiu)》等(deng)課(ke)題(ti)。科(ke)(ke)(ke)室總的科(ke)(ke)(ke)研(yan)經費超過200多萬元。培養(yang)醫學博士(shi)(shi)(在(zai)職)5名,醫學碩士(shi)(shi)16名。主(zhu)(zhu)編著作1部,參編著作1部,在(zai)國(guo)(guo)內外期(qi)刊上發(fa)表論文60余篇(pian)。其(qi)中(zhong)以(yi)SCI收錄文獻15篇(pian),單(dan)篇(pian)SCI影響因子(zi)最高5.2,累計(ji)影響因子(zi)達32。

目前加拿大(da)(da)pc開獎甲狀腺(xian)乳(ru)腺(xian)外科(ke)是魯(lu)北(bei)地(di)區集臨(lin)床、教學(xue)、科(ke)研于一(yi)體(ti)的甲狀腺(xian)乳(ru)腺(xian)疾病診療中(zhong)心,為(wei)全國乳(ru)腺(xian)癌臨(lin)床數據協助組單位(wei)、中(zhong)國乳(ru)腺(xian)微創與腔鏡手(shou)術聯盟成員單位(wei)、山(shan)(shan)東省區域乳(ru)腺(xian)中(zhong)心聯盟分中(zhong)心,山(shan)(shan)東省青年文明號科(ke)室(shi)、山(shan)(shan)東省臨(lin)床重(zhong)點(dian)專科(ke)、濱(bin)(bin)州醫(yi)學(xue)院(yuan)重(zhong)點(dian)科(ke)室(shi)、濱(bin)(bin)州醫(yi)學(xue)院(yuan)創新(xin)團隊、加拿大(da)(da)pc臨(lin)床重(zhong)點(dian)專科(ke),連(lian)年獲得(de)患者最滿(man)意(yi)科(ke)室(shi)。

】【打印關閉】 【返回頂部